|Application||Project Stage||Development Target|
|Alzheimer's type dementia||Formulation study||In an aging society, needs for transdermal medicine are growing since many aged patients have difficulty of swallowing oral medicaments. Transdermal medicines can give convenience for nurses, care personnel and patients.
Aiming to change oral dosage medicines to transdermal formulations.
Target of our formulation: Various duration such as one day to one week.
|Nausea & vomiting||Completion of formulation study
|Improvement of transdermal formulations approved in the US and Europe.
Target of our formulation: Fast-acting
|Hypertension||Formulation study||Improvement of transdermal formulations approved in the US.
Target of our formulation: One week patch with less skin irritation and controlling drug release.
* See R&D Plan